{"nct_id":"NCT04400331","title":"Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-12","start_date":"2020-09-18","start_date_type":"ACTUAL","primary_completion_date":"2026-03","primary_completion_date_type":"ESTIMATED","completion_date":"2026-03","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NBIX"]}